⌘K

Login Start Free

Home/Filings/4/0001144204-17-033625

4//SEC Filing

EYEGATE PHARMACEUTICALS INC 4

Accession 0001144204-17-033625

$KPRXCIK 0001372514operating

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 4:20 PM ET

Size

5.4 KB

Accession

0001144204-17-033625

Insider Transaction Report

Form 4

Period: 2017-06-21

EYEGATE PHARMACEUTICALS INCEYEG

Director

Transactions

Award
Stock Option (right to buy)
2017-06-21+15,000→ 15,000 total
Exercise: $1.35Exp: 2027-06-21→ Common Stock (15,000 underlying)

Footnotes (1)

[F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to 100% of the shares underlying the Option on June 21, 2018.

Documents

1 file

4
v469454_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeoperating

Related Parties

1

filerCIK 0001372514

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 4:20 PM ET
Size: 5.4 KB

View on SEC.gov